Mylan Laboratories Limited Sofosbuvir Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Sofosbuvir Export Records India — #1 Exporter, 199 Shipments, $9.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sofosbuvir

India Pharmaceutical Trade Intelligence

$40.9M150 Suppliers113 CountriesHS 30049099

ExportsIndia → VIETNAM12.4%India → ETHIOPIA9.2%

ImportsUNITED STATES → India$206.1K GERMANY → India$43.1K

#1 Supplier: MYLAN LABORATORIES

Mylan Laboratories Limited — Sofosbuvir Exporter #1 | $9.9M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Sofosbuvir Exporter Profile

Indian Pharmaceutical Exporter · #1 for Sofosbuvir · $9.9M export value · DGFT Verified

Mylan Laboratories Limited is the #1 Indian exporter of Sofosbuvir with $9.9M in export value and 199 verified shipments. Mylan Laboratories Limited holds a 24.3% market share in Sofosbuvir exports across 44 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Sofosbuvir Export Profile: Buyers & Destinations

Mylan Laboratories Limited Sofosbuvir export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Sofosbuvir?

Country	Value	Shipments	Share
ETHIOPIA	$533.4K	11	7.9%
KAZAKISTAN	$414.0K	11	6.2%
GEORGIA	$408.6K	9	6.1%
VIETNAM, DEMOCRATIC REP. OF	$400.0K	8	5.9%
TURKMENISTAN	$392.9K

Who Are the Top Buyers of Sofosbuvir from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
UNDP OFFICE IN TURKMENISTAN	TURKMENISTAN	$392.9K	10
ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY EPSA ADDIS ABABAP O	ETHIOPIA	$300.0K	6
WORLD HEALTH ORGANIZATION	AFGHANISTAN	$254.0K	7
TOO-L-PHARMA	KAZAKISTAN	$231.7K	7
UNOPS MYANMAR OC	MYANMAR	$200.0K	4
MSF SUPPLY C.V,	BELGIUM	$193.3K	6
TOO-"L-PHARMA",	KAZAKISTAN	$182.3K	4
NATIONAL TB CONTROL PROGRAM (NTP)	PAKISTAN	$150.0K	3
DELTA IMPORT EXPORT MEDICAL CO	VIETNAM	$150.0K	3
UNITED NATIONS DEVELOPMENT PROGRAMM	KYRGHYSTAN	$150.0K	3

Mylan Laboratories Limited supplies Sofosbuvir to 99 buyers globally. The largest buyer is UNDP OFFICE IN TURKMENISTAN (TURKMENISTAN), followed by ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY EPSA ADDIS ABABAP O (ETHIOPIA) and WORLD HEALTH ORGANIZATION (AFGHANISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sofosbuvir Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
SOFOSBUVIR 400MG + DACLATASVIR 60MG TABL	$203.7K	5
SOFOSBUVIR 400MG+DACLATASVIR 60MG TABLET	$176.9K	7
SOFOSBUVIR 400MG + VELPATASVIR 100MG TAB	$150.0K	3
SOFOSBUVIR 400MG + DACLATASVIR 60MG TABLETS 28'S - MYHEP DVIR 19749 PACKS X 28 NOS	$150.0K	3
SOFOSBUVIR 400MG + DACLATASVIR 60MG TABLETS 28'S - MYHEP DVIR 19749 PACKS X 28 NOS.	$150.0K	3
MYVELPA -- SOFOSBUVIR 400MG-VELPATASVIR 100MG 28BT 28'S BOTTLE	$150.0K	3
SOFOSBUVIR VELPATASVIR, TABLETS 400MG 100MG HDPE BOTTLE OF 28 PACKS 6600NOS	$150.0K	3
MYHEP ALL SOFOSBUVIR + VELPATASVIR 400MG100MG 28BT TAB PACKS 4763NOS	$150.0K	3
MY HEP SOFOSBUVIR TAB 400MG 28BT KZ MY PACK 17000NOS	$150.0K	3
Sofosbuvir 400mg + Daclatasvir 60mg Tabl	$138.0K	3

Mylan Laboratories Limited exports 136 distinct Sofosbuvir formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SOFOSBUVIR 400MG + DACLATASVIR 60MG TABL with 5 shipments worth $203.7K.

How Does Mylan Laboratories Limited Compare to Nearest Sofosbuvir Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED ★	$9.9M	199	44	$50.0K
2	HETERO LABS LIMITED	$5.3M	105	18	$50.0K
4	NATCO PHARMA LIMITED	$800.0K	16	7	$50.0K

Mylan Laboratories Limited ranks #1 among 150 Indian Sofosbuvir exporters. Average shipment value of $50.0K compared to the market average of $120.8K. The closest competitors by value are HETERO LABS LIMITED and NATCO PHARMA LIMITED.

Which Indian Ports Ship Sofosbuvir Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	357	26.6%
SAHAR AIR	269	20.1%
DELHI AIR CARGO ACC (INDEL4)	158	11.8%
Bombay Air	126	9.4%
DELHI AIR	79	5.9%
AHEMDABAD AIR	68	5.1%
AHEMDABAD AIR ACC (INAMD4)	50	3.7%
HYDERABAD ACC (INHYD4)	39	2.9%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Sofosbuvir Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sofosbuvir shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 199 individual customs records matching Mylan Laboratories Limited exporting Sofosbuvir, covering 136 formulations to 47 countries via 99 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 113+ countries, 377+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sofosbuvir

Sofosbuvir

Mylan Laboratories Limited — Sofosbuvir Exporter Profile

Mylan Laboratories Limited — Sofosbuvir Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Sofosbuvir?

Who Are the Top Buyers of Sofosbuvir from Mylan Laboratories Limited?

What Is India's Total Sofosbuvir Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Sofosbuvir Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Sofosbuvir Exporters?

What Sofosbuvir Formulations Does Mylan Laboratories Limited Export?

How Does Mylan Laboratories Limited Compare to Nearest Sofosbuvir Exporters?

Which Indian Ports Ship Sofosbuvir Exports?

What Other Antiviral & HIV Medications Products Does Mylan Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Sofosbuvir Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sofosbuvir Export Data from Mylan Laboratories Limited

Sofosbuvir Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source